StonvexLoading…
StonvexStonvexStonvexCore line items from CASIF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $28.54M | $33.88M | $38.05M | $30.02M |
Operating Income | $-39.62M | $-25.08M | $-34.03M | $-41.52M |
Net Income | $-39.26M | $-26.96M | $-41.01M | $-36.65M |
EPS (Diluted) | $-2.56 | $-2.02 | $-3.01 | $-2.69 |
Total Assets | $53.67M | $75.27M | $96.23M | $138.30M |
Total Liabilities | $51.82M | $51.10M | $29.30M | $30.34M |
Cash & Equivalents | $13.47M | $17.08M | $47.11M | $38.70M |
Free Cash Flow OCF − CapEx | $-29.45M | $-20.17M | $-26.70M | $-35.79M |
Shares Outstanding | 15.49M | 13.38M | 13.46M | 13.98M |